NeuPath Health

NeuPath Health Gross Margin

The Gross Margin of NeuPath Health (NPTH.V) as of Nov 12, 2026 is 19.03 %. In the previous year, Gross Margin was 19.03 % — a change of -0.02% (lower).

Gross Margin

19.03 %

YoY

-0.02%

Last updated:

Gross Margin of NeuPath Health is 2025 19.03 % . Gross Margin of NeuPath Health was 2024 19.03 % . It decreases by -0.02% lower compared to the previous year.

For NeuPath Health, the gross margin of 19.0% is broadly stable versus 18.2% a few years ago.

The NeuPath Health Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
20.06 CAD
Jan 1, 2020
20.40 CAD
Jan 1, 2021
18.25 CAD
Jan 1, 2022
17.27 CAD
Jan 1, 2023
18.60 CAD
Jan 1, 2024
19.03 CAD
Jan 1, 2025
19.03 CAD
The NeuPath Health Gross Margin history
YEARGross MarginYoY
19.03 %-0.02%
19.03 %+2.32%
18.60 %+7.73%
17.27 %-5.37%
18.25 %-10.55%
20.40 %+1.71%
20.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeuPath Health Stock analysis

What does NeuPath Health do? NeuPath Health, Inc. generates revenue through chronic pain management services provided at its clinics in Ontario and Alberta, offering comprehensive assessments and rehabilitation for chronic pain, musculoskeletal/back injuries, sports injuries, and concussions. The company serves employers and disability insurers with workplace health services and independent medical assessments via a national network of healthcare providers. Additionally, NeuPath provides contract research services to pharmaceutical and biotechnology companies. Its healthcare providers include physiatrists, neurologists, anesthesiologists, general practitioners with specialized pain training, medication management physicians, athletic therapists, and nurses. The primary buyers of NeuPath's services are employers and disability insurers seeking workplace health solutions and independent medical evaluations. Pharmaceutical and biotechnology companies contract NeuPath for research services. The company's clinic services target patients with chronic pain conditions, while its research division serves the pharmaceutical industry. NeuPath's network spans Ontario and Alberta, with a focus on specialized medical expertise across multiple disciplines. NeuPath Health, Inc. operates a network of medical clinics delivering chronic pain management and rehabilitation services. Its national provider network supports workplace health and independent medical assessments for employers and disability insurers. The firm's contract research division works with pharmaceutical and biotechnology companies, leveraging its medical expertise in pain management and rehabilitation. The company's service mix combines direct patient care with specialized industry contracts, creating multiple revenue streams from healthcare providers and corporate clients. NeuPath Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeuPath Health stock

Gross Margin of NeuPath Health is 19.03 % in 2025.

Gross Margin of NeuPath Health changed from 19.03 % to 19.03 %, representing a -0.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin NeuPath Health since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's NeuPath Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — NeuPath Health

All Key Metrics — NeuPath Health